Clinical characteristics and treatment modalities in women with newly diagnosed advanced high-grade serous epithelial ovarian cancer in Taiwan

HENG-CHENG HSUChou, Hung-HsuehHung-HsuehChouWEN-FANG CHENGChang, Chih-LongChih-LongChang2024-03-282024-03-282024-03-060929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/641553This study was designed to investigate the demographics, treatment patterns, and clinical outcomes of patients newly diagnosed with high-grade serous ovarian cancer (HGSOC) in 3 medical centers in Taiwan before the integration of poly (ADP-ribose) polymerase inhibitors in clinical practice.enHigh-grade serous ovarian cancer; Interval debulking surgery; Primary cytoreductive surgery[SDGs]SDG1[SDGs]SDG3[SDGs]SDG5Clinical characteristics and treatment modalities in women with newly diagnosed advanced high-grade serous epithelial ovarian cancer in Taiwanjournal article10.1016/j.jfma.2024.01.032384535302-s2.0-85187367261https://api.elsevier.com/content/abstract/scopus_id/85187367261